At HOOKIPA, we envision a world in which cancers and infectious diseases can be chronically managed or eradicated. 

HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company advancing the field of immunotherapy through the development of new immunotherapies based on our proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease.

Our pipeline includes wholly owned investigational arenaviral immunotherapies targeting HPV16+ cancers, prostate cancer, KRAS-mutated cancers (including colorectal, pancreatic and lung), and other undisclosed programs. In addition, HOOKIPA aims to develop functional cures for HBV and HIV in collaboration with Gilead.

As a company, we fight for innovation; we challenge ourselves to act authentically and transparently; we thrive on our differences; and we go for it, never giving up in our efforts to eliminate the suffering of people with cancer and infectious disease.

To learn more please visit www.hookipapharma.com. 


Biotechnology

Life Sciences

Pharmaceutical

HOOKIPA Pharma Inc.

HOOKIPA Pharma Inc.'s headquarters in New York, NY, United States

Ilian Tchakov

Jan Micksch

James Lam

Reinhard Kandera

Silvia S.

Siddhi Patel

The Leadership Team at HOOKIPA Pharma Inc. consists of key executives responsible for strategic decision-making and guiding the company’s mission to develop innovative immunotherapies. This team includes experts across various domains such as scientific research, finance, operations, legal matters, and business development, united to drive the company’s goal of eradicating cancers and infectious diseases through cutting-edge therapeutic solutions.

Leadership Team

The Quality and Supply Chain Team at HOOKIPA Pharma Inc. ensures the highest standards of product quality and regulatory compliance across all stages of drug development and production. This team oversees the efficient management of the supply chain, coordinates with external manufacturing partners, optimizes supply chain processes through digital transformation, and guarantees that clinical operations run smoothly by maintaining a reliable supply of investigational therapies.

Quality and Supply Chain Team

The Research and Development team at HOOKIPA Pharma Inc. focuses on pioneering the development of advanced immunotherapies using their proprietary arenavirus platform. This team integrates expertise in virology, bioinformatics, immunology, and clinical biomarkers to design, test, and refine treatments targeting various cancers, including HPV16+ and KRAS-mutated cancers, and infectious diseases such as HBV and HIV. With roles ranging from vice presidents to junior scientists, they work collaboratively to push the boundaries of innovation, aiming to create functional cures and improve the quality of life for patients.

Research and Development

The Finance Team at HOOKIPA Pharma Inc. is responsible for managing the financial aspects of the company, ensuring accurate accounting, controlling costs, and providing strategic financial planning. The team, led by the Chief Financial Officer, supports the company's mission by optimizing financial performance, overseeing budget management, and guiding investment decisions to sustain HOOKIPA's innovative immunotherapy development and collaborative projects.

HOOKIPA Pharma Inc.

Org chart

Teams

Leadership Team

Quality and Supply Chain Team

Research and Development

Finance Team

Offices

HOOKIPA Pharma Inc.

Org chart

Teams

Leadership Team

Quality and Supply Chain Team

Research and Development

Finance Team

Offices

Related companies